Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study

por A. Malhani, Areej, A. Enani, Mushira, Saheb Sharif-Askari, Fatemeh, R. Alghareeb, Mona, T. Bin-Brikan, Roaa, A. AlShahrani, Safar, Halwani, Rabih, Tleyjeh, Imad M.
Publicado 2021